Skip to main content
. Author manuscript; available in PMC: 2021 Apr 28.
Published in final edited form as: Neuron. 2020 Oct 28;108(2):286–301. doi: 10.1016/j.neuron.2020.10.001

Figure 1.

Figure 1

“Eroom’s” versus Moore’s Law. (Top panel) Inflation-adjusted R&D costs from 1950-2010 pharma R&D efficiency (reproduced with permission from (Scannell et al., 2012). (Lower panel) The decrease in the cost of a transistor over time, following Moore’s projection (Intel/WSTS, 2005(David Brock, 2006)). Note that FDA-related events and biotechnology innovations appear to have a modest impact on the major trend over several decades.